Results 21 to 30 of about 510,668 (221)
European Society of Cardiology Core Curriculum for Cardio-Oncology. [PDF]
, 2023 Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant ...
Barac, Ana +33 more
core +5 more sources
Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field [PDF]
Frontiers in Cardiovascular Medicine, 2018 The management of cardiovascular disease in patients with active cancer presents a unique challenge in interventional cardiology. Cancer patients often suffer from significant comorbidities such as thrombocytopenia and coagulopathic and/or ...
Victor Y. Liu +11 more
doaj +3 more sources
Nursing knowledge in cardio-oncology: results of an international learning needs-assessment survey
Cardio-OncologyBackground With early detection and improvements in systemic and local therapies, millions of people are surviving cancer, but for some at a high cost. In some cancer types, cardiovascular disease now competes with recurrent cancer as the cause of death.
Anecita Fadol +7 more
doaj +2 more sources
Natriuretic Peptides, Cardio-Oncology
Anatolian Journal of Cardiology, 2023 Çetin Erol
doaj +3 more sources
Clinical Medicine, 2023 Cardio-oncology is a subspecialty that provides cardiac care for patients with cancer. Newer oncological agents have not only increased survivorship, but also sprouted novel cardiovascular toxicity (CVT) involving any component of the cardiovascular system, albeit with some preferential targets.
Ferreira, Vera Vaz, Ghosh, Arjun K
openaire +2 more sources
An update on cardio-oncology [PDF]
Trends in Cardiovascular Medicine, 2014 Over the past decades, there have been great advancements in the survival outcome of patients with cancer. As a consequence, treatment regimens are being extended to patient populations that would not have qualified in the past based on comorbidities and age.
Joerg, Herrmann, Amir, Lerman
openaire +2 more sources
The Oncologist, EarlyView., 2021 Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi +21 more
wiley +1 more source
Focused echocardiography in cardio‐oncology [PDF]
Echocardiography, 2020 AbstractTransthoracic echocardiography (TTE) is the cornerstone of imaging in patients with a malignancy in all stages of their treatment—before, during, and after the completion of it—to identify most of the cardiotoxic complications. However, the restricted time and resources of cardio‐oncology services and the high volume of oncological patients and
Kalliopi Keramida +3 more
openaire +4 more sources
Precision Cardio-Oncology [PDF]
Journal of Nuclear Medicine, 2019 Modern oncologic therapies and care have resulted in a growing population of cancer survivors with comorbid, chronic health conditions. As an example, many survivors have an increased risk of cardiovascular complications secondary to cardiotoxic systemic and radiation therapies.
Alexandra D, Dreyfuss +3 more
openaire +2 more sources